{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:36:03Z","timestamp":1793068563781,"version":"4.5.0"},"reference-count":41,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Myasthenia Gravis (MG) and myasthenic syndrome (MSyn) are neurological disorders induced by different types of autoantibodies, characterized by generalized muscle weakness, sometimes involving the respiratory muscles and necessitating ventilatory support. One therapeutic option for severe Myasthenia Gravis (MG) is total plasma exchange (TPE). This procedure reduces the concentration of autoantibodies by extracting the patient\u2019s plasma and replacing it with donor plasma. The TPE efficacy varies among different types of MG, and patient response to TPE is evaluated solely through clinical markers, such as muscle strength. So far, no laboratory method is available for monitoring TPE treatment progress. Objective: In this study, we aimed to determine whether differential scanning calorimetry (DSC) of blood plasma from myasthenic patients is an appropriate tool to monitor and evaluate their condition and the TPE effect. Methods: We performed DSC prior to and after TPE course on blood plasma from three patients with different types of MG: Case 1. Patient with Acetylcholine Receptor Myasthenia Gravis (AChR MG); Case 2. Patient with Muscle-specific tyrosine kinase Myasthenia Gravis (MuSK MG); Case 3. Patient with Myasthenic syndrome (MSyn). Results: DSC thermogram examination revealed increased plasma protein fractions, primarily immunoglobulins (IG), as well as to some extent fibrinogen, relative to a suppressed serum albumin fraction. Successive TPE procedures resulted in IG fraction decline in AChR MG (Case 1) and MSyn (Case 3), and upsurge of the IG fraction in MuSK MG (Case 2). These findings aligned with the clinical presentation of all three cases. Conclusions: DSC revealed distinct, very significant differences in the heat capacity profiles of blood plasma from MG patients relative to healthy controls, as well as strong TPE influence on the plasma thermal behavior. DSC showed promise as a reliable and informative technique for the monitoring of myasthenia and TPE effects across diverse myasthenic patient populations. Further research is needed to confirm and expand on these findings.<\/jats:p>","DOI":"10.3390\/jcm14144968","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T10:55:41Z","timestamp":1752490541000},"page":"4968","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Differential Scanning Calorimetry as a Monitoring Tool for the Effectiveness of Therapeutic Plasma Exchange in Anti-AChR Myasthenia Gravis, Anti-MuSK Myasthenia Gravis, and Myasthenic Syndrome: A Case Series"],"prefix":"10.3390","volume":"14","author":[{"given":"Viktoria","family":"Ilieva","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, University Hospital \u201cAlexandrovska\u201d, Georgi Sofiiski Str. No. 1, 1000 Sofia, Bulgaria"},{"name":"Medical Faculty, Medical University of Sofia, Akad. Ivan Geshov Blvd. No. 15, 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2065-9086","authenticated-orcid":false,"given":"Boris","family":"Tenchov","sequence":"additional","affiliation":[{"name":"Medical Faculty, Medical University of Sofia, Akad. Ivan Geshov Blvd. No. 15, 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Virovska","sequence":"additional","affiliation":[{"name":"Medical Faculty, Medical University of Sofia, Akad. Ivan Geshov Blvd. No. 15, 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denitsa","family":"Nencheva","sequence":"additional","affiliation":[{"name":"Medical Faculty, Medical University of Sofia, Akad. Ivan Geshov Blvd. No. 15, 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksim","family":"Kalayanov","sequence":"additional","affiliation":[{"name":"Medical Faculty, Medical University of Sofia, Akad. Ivan Geshov Blvd. No. 15, 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandar","family":"Farfarov","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, University Hospital \u201cAlexandrovska\u201d, Georgi Sofiiski Str. No. 1, 1000 Sofia, Bulgaria"},{"name":"Medical Faculty, Medical University of Sofia, Akad. Ivan Geshov Blvd. No. 15, 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yordanka","family":"Yamakova","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, University Hospital \u201cAlexandrovska\u201d, Georgi Sofiiski Str. No. 1, 1000 Sofia, Bulgaria"},{"name":"Medical Faculty, Medical University of Sofia, Akad. Ivan Geshov Blvd. No. 15, 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1614-4282","authenticated-orcid":false,"given":"Silviya","family":"Abarova","sequence":"additional","affiliation":[{"name":"Medical Faculty, Medical University of Sofia, Akad. Ivan Geshov Blvd. No. 15, 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Dresser, L., Wlodarski, R., Rezania, K., and Soliven, B. (2021). Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations. J. Clin. Med., 10.","DOI":"10.3390\/jcm10112235"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1038\/s41433-024-03133-x","article-title":"Treating myasthenia gravis beyond the eye clinic","volume":"38","author":"Jacob","year":"2024","journal-title":"Eye"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.12688\/f1000research.8206.1","article-title":"Pathogenesis of myasthenia gravis: Update on disease types, models, and mechanisms","volume":"5","author":"Phillips","year":"2016","journal-title":"F1000Research"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/TCRM.S14015","article-title":"Current and emerging treatments for the management of myasthenia gravis","volume":"7","author":"Sathasivam","year":"2011","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Koneczny, I., and Herbst, R. (2019). Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture. Cells, 8.","DOI":"10.3390\/cells8070671"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.expneurol.2015.03.010","article-title":"Standardization of the Experimental Autoimmune Myasthenia Gravis (EAMG) Model by Immunization of Rats with Torpedo Californica Acetylcholine Receptors-Recommendations for Methods and Experimental Designs","volume":"270","author":"Losen","year":"2015","journal-title":"Exp. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Cao, M., Koneczny, I., and Vincent, A. (2020). Myasthenia Gravis with Antibodies Against Muscle Specific Kinase: An Update on Clinical Features, Pathophysiology and Treatment. Front. Mol. Neurosci., 13.","DOI":"10.3389\/fnmol.2020.00159"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","article-title":"Complement associated pathogenic mechanisms in myasthenia gravis","volume":"12","author":"Christadoss","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3949\/ccjm.90a.22017","article-title":"Myasthenia gravis: Frequently asked questions","volume":"90","author":"Morren","year":"2023","journal-title":"Clevel. Clin. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-musk antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1749-6632.2012.06781.x","article-title":"Management challenges in muscle-specific tyrosine kinase myasthenia gravis","volume":"1274","author":"Evoli","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Farrugia, M.E., and Goodfellow, J.A. (2020). A Practical Approach to Managing Patients with Myasthenia Gravis\u2014Opinions and a Review of the Literature. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.00604"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Lipe, D.N., Qdaisat, A., Krishnamani, P.P., Nguyen, T.D., Chaftari, P., Messiri, N., Srinivasan, A., Galvis-Carvajal, E., Reyes-Gibby, C.C., and Wattana, M.K. (2024). Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A Systematic Review. Diagnostics, 14.","DOI":"10.3390\/diagnostics14161794"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Heldal, A.T., Eide, G.E., Romi, F., Owe, J.F., and Gilhus, N.E. (2014). Repeated Acetylcholine Receptor Antibody-Concentrations and Association to Clinical Myasthenia Gravis Development. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0114060"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Luo, L., Zhu, X., Wen, C., Guo, Y., Yang, J., Wei, D., Yu, P., and Wan, M. (2025). Exploring the clinical significance of anti-acetylcholine receptor antibody titers, changes, and change rates in Myasthenia Gravis. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1506845"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/ene.15238","article-title":"The association between anti-acetylcholine receptor antibody level and clinical improvement in myasthenia gravis","volume":"29","author":"Marcuse","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1529\/biophysj.107.119453","article-title":"Calorimetry Outside the Box: A New Window into the Plasma Proteome","volume":"94","author":"Garbett","year":"2008","journal-title":"Biophys. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.yexmp.2008.12.001","article-title":"Differential scanning calorimetry of blood plasma for clinical diagnosis and monitoring","volume":"86","author":"Garbett","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.bbrc.2007.02.042","article-title":"A broad range of Fab stabilities within a host of therapeutic IgGs","volume":"355","author":"Garber","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Garbett, N.C., Merchant, M.L., Helm, C.W., Jenson, A.B., Klein, J.B., and Chaires, J.B. (2014). Detection of Cervical Cancer Biomarker Patterns in Blood Plasma and Urine by Differential Scanning Calorimetry and Mass Spectrometry. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0084710"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1021\/ac503677d","article-title":"Calorimetric Markers of Bence Jones and Nonsecretory Multiple Myeloma Serum Proteome","volume":"86","author":"Todinova","year":"2014","journal-title":"Anal. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7992","DOI":"10.1021\/ac202055m","article-title":"Microcalorimetry of Blood Serum Proteome: A Modified Interaction Network in the Multiple Myeloma Case","volume":"83","author":"Todinova","year":"2011","journal-title":"Anal. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tca.2015.07.002","article-title":"Calorimetric features of IgM gammopathies. Implication for patient\u2019s diagnosis and monitoring","volume":"615","author":"Krumova","year":"2015","journal-title":"Thermochim. Acta"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1373\/clinchem.2007.091165","article-title":"Interrogation of the Plasma Proteome with Differential Scanning Calorimetry","volume":"53","author":"Garbett","year":"2007","journal-title":"Clin. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10973-009-0602-6","article-title":"Differential scanning calorimetry study of blood serum in chronic obstructive pulmonary disease","volume":"102","author":"Michnik","year":"2010","journal-title":"J. Therm. Anal. Calorim."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s10973-016-5495-6","article-title":"Role of differential scanning calorimetry (DSC) in the staging of COPD","volume":"127","author":"Szalai","year":"2017","journal-title":"J. Therm. Anal. Calorim."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1227\/01.neu.0000430296.23799.cd","article-title":"Differential Scanning Calorimetry of Gliomas: A new tool in brain cancer diagnostics?","volume":"73","author":"Chagovetz","year":"2013","journal-title":"Neurosurgery"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tca.2013.09.015","article-title":"Calorimetric monitoring of the serum proteome in schizophrenia patients","volume":"572","author":"Krumova","year":"2013","journal-title":"Thermochim. Acta"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tca.2017.11.001","article-title":"Beneficial effect of sequential chemotherapy treatments of lung cancer patients revealed by calorimetric monitoring of blood plasma proteome denaturation","volume":"659","author":"Koynova","year":"2018","journal-title":"Thermochim. Acta"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1007\/s10973-015-4642-9","article-title":"Influence of oxidative injury and monitoring of blood plasma by DSC on breast cancer patients","volume":"123","author":"Zapf","year":"2016","journal-title":"J. Therm. Anal. Calorim."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10973-016-5291-3","article-title":"Harmful effect of neoadjuvant chemotherapy monitoring by DSC on breast cancer patients\u2019 blood plasma","volume":"126","author":"Ferencz","year":"2016","journal-title":"J. Therm. Anal. Calorim."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tca.2018.12.001","article-title":"Blood plasma thermal behavior and protein oxidation as indicators of multiple sclerosis clinical status and plasma exchange therapy progression","volume":"671","author":"Tenchov","year":"2019","journal-title":"Thermochim. Acta"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice\u2014Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue","volume":"28","author":"Schwartz","year":"2013","journal-title":"J. Clin. Apher."},{"key":"ref_34","first-page":"5","article-title":"National consensus for the intensive treatment of diseases by therapeutic apheresis","volume":"2","author":"Kenarov","year":"2014","journal-title":"Anesthesiol. Intens. Care"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1021\/bi00524a042","article-title":"Thermal denaturation of Streptomyces subtilisin inhibitor, subtilisin BPN\u2019, and the inhibitor-subtilisin complex","volume":"20","author":"Takahashi","year":"1981","journal-title":"Biochemistry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e318207b1f6","article-title":"Evidence-based guideline update: Plasmapheresis in neurologic disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"76","author":"Cortese","year":"2011","journal-title":"Neurology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/1744-9987.14065","article-title":"Serum immunoglobulin G level reduction is a predictor of short-term improvement in patients with myasthenia gravis undergoing plasmapheresis","volume":"28","author":"Konno","year":"2024","journal-title":"Ther. Apher. Dial."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/08916934.2016.1214823","article-title":"Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis","volume":"49","author":"Guptill","year":"2016","journal-title":"Autoimmunity"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/mus.23944","article-title":"The Muscle Study Group Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?","volume":"49","author":"Sanders","year":"2014","journal-title":"Muscle Nerve"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1212\/WNL.28.3.266","article-title":"Function of circulating antibody to acetylcholine receptor in myasthenia gravis: Investigation by plasma exchange","volume":"28","author":"Pinching","year":"1978","journal-title":"Neurology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s004150070149","article-title":"Comparison between double-filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis","volume":"247","author":"Yeh","year":"2000","journal-title":"J. Neurol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/14\/4968\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:09:31Z","timestamp":1760033371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/14\/4968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":41,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["jcm14144968"],"URL":"https:\/\/doi.org\/10.3390\/jcm14144968","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]}}}